NEW YORK (GenomeWeb) – Exact Sciences today announced that Aetna will cover its Cologuard test under its Medicare Advantage plan, which serves 967,000 members across the country.

The three-year contract goes into effect on April 1, 2015, the Madison, Wis.-based molecular diagnostics firm said. Cologuard will be available to Aetna's Medicare Advantage members through their physician without a co-payment or co-insurance, Exact Sciences noted.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.